Sanofi (SNY) Debt to Equity (2016 - 2025)
Sanofi's Debt to Equity history spans 10 years, with the latest figure at $0.2 for Q4 2025.
- For Q4 2025, Debt to Equity fell 3.3% year-over-year to $0.2; the TTM value through Dec 2025 reached $0.2, down 3.3%, while the annual FY2025 figure was $0.2, 3.3% down from the prior year.
- Debt to Equity for Q4 2025 was $0.2 at Sanofi, down from $0.21 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.3 in Q4 2021 and bottomed at $0.2 in Q4 2025.
- The 5-year median for Debt to Equity is $0.22 (2023), against an average of $0.24.
- The largest annual shift saw Debt to Equity fell 17.12% in 2021 before it dropped 3.3% in 2025.
- A 5-year view of Debt to Equity shows it stood at $0.3 in 2021, then fell by 13.93% to $0.25 in 2022, then fell by 13.0% to $0.22 in 2023, then fell by 6.76% to $0.21 in 2024, then dropped by 3.3% to $0.2 in 2025.
- Per Business Quant, the three most recent readings for SNY's Debt to Equity are $0.2 (Q4 2025), $0.21 (Q4 2024), and $0.22 (Q4 2023).